AR088461A1 - Uso de derivados de aminoacetonitrilo contra endoparasitos - Google Patents
Uso de derivados de aminoacetonitrilo contra endoparasitosInfo
- Publication number
- AR088461A1 AR088461A1 ARP120103892A ARP120103892A AR088461A1 AR 088461 A1 AR088461 A1 AR 088461A1 AR P120103892 A ARP120103892 A AR P120103892A AR P120103892 A ARP120103892 A AR P120103892A AR 088461 A1 AR088461 A1 AR 088461A1
- Authority
- AR
- Argentina
- Prior art keywords
- cyano
- benzamide
- pentafluorothium
- methylethyl
- phenoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicación 1: Un método para tratar una infección endoparasitaria causada por filarias en un animal que lo necesita, caracterizado porque comprende administrar al animal una cantidad eficaz de un compuesto de la fórmula (1), un estereoisómero o una sal de este aceptable en veterinaria en donde: R¹, R², R³, R⁴ y R⁵ se seleccionan cada uno independientemente de H, halo, CN, CF₃, metilo, metoxi, -OCF₃ y -SCH₃, en donde el compuesto es eficaz para tratar la infección endoparasitaria. Reivindicación 3: El método de acuerdo con la reivindicación 2, caracterizado porque el compuesto de la fórmula (1) se selecciona del grupo que consiste en: N-{1-ciano-2-[3-ciano-5-(trifluorometil)fenoxi]-metiletiI}-4-(pentafluorotio)-benzamida; N-[2-(2-bromo-5-cianofenoxi)-1-ciano-1-metiletiI]-4-(pentafluorotio)-benzamida; y@@@N-{(1S)1-ciano-2-[4-ciano-2-(trifluorometil)fenoxi]-1-metiletil}-4-pentafluorotiobenzamida, un estereoisómero de aquel, o una sal del compuesto aceptable en veterinaria o un estereoisómero de esta. Reivindicación 4: Un método para tratar una infección endoparasitaria causada por filarias en un animal que lo necesita, caracterizado porque comprende administrar al animal una cantidad eficaz de un compuesto de la fórmula (2), un estereoisómero o una sal de este aceptable en veterinaria, en donde: en donde R¹ᵃ, R¹ᵇ, R¹ᶜ, R¹ᵈ y R¹ᵉ se seleccionan cada uno independientemente del grupo que consiste en hidrógeno, halo, CF₃, -OCH₃, metilo e hidroxilo. Reivindicación 15: Un compuesto caracterizado porque es seleccionado del grupo que consiste de: N-{1-ciano-2-[5-ciano-2-(4-fluorofenoxi)fenoxi]-1-metiletiI}-4-(pentafluorotio)benzamida; N-{2-[2-(4-cloro-2-fluorofenoxi)-5-cianofenoxi]-1-ciano-1-metiletil)-4-(pentafluorotio)benzamida; N-{2-[2-(4-clorofenoxi)-5-cianofenoxi]-1-ciano-1-metiletil}-4-(pentafluorotio)benzamida; N-(1-ciano-2-{5-ciano-2-[4-(trifluorometil)fenoxi]fenoxi}-1-metiletil)-4-(pentafluorotio)benzamida. N-{2-[2-(2-cloro-4-metilfenoxi)-5-cianofenoxi]-1-ciano-1-metiletil}-4-(pentafluorotio)benzamida; N-{1-ciano-2-[5-ciano-2-(2,4-dimetilfenoxi)fenoxi]-1-metiletil}-4-(pentafluorotio)benzamida y N-{1-ciano-2-[5-ciano-2-(3,5-difIuoro-4-metoxifenoxi)fenoxi]-1-metiletil}-4-(pentafluorotio)benzamida, estereoisómeros y sales de aquel aceptables en veterinaria o en farmacia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549027P | 2011-10-19 | 2011-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR088461A1 true AR088461A1 (es) | 2014-06-11 |
Family
ID=47278351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120103892A AR088461A1 (es) | 2011-10-19 | 2012-10-18 | Uso de derivados de aminoacetonitrilo contra endoparasitos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8962681B2 (es) |
| EP (1) | EP2768497A1 (es) |
| JP (2) | JP2014530849A (es) |
| CN (1) | CN104271128A (es) |
| AR (1) | AR088461A1 (es) |
| AU (1) | AU2012324491A1 (es) |
| BR (1) | BR112014009220A8 (es) |
| CA (1) | CA2851412A1 (es) |
| MX (1) | MX2014004743A (es) |
| WO (1) | WO2013057624A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2973383A1 (en) * | 2015-01-09 | 2016-07-14 | Abbvie Inc. | Treatment of filarial diseases |
| CN107183328A (zh) * | 2017-06-28 | 2017-09-22 | 江苏农牧科技职业学院 | 一种防治血液寄生虫的宠物饲料及其制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO176766C (no) | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
| JPH0570366A (ja) | 1991-03-08 | 1993-03-23 | Meiji Seika Kaisha Ltd | 薬用組成物 |
| CA2132199C (en) | 1992-03-17 | 2000-01-18 | Hitoshi Nishiyama | Depsipeptide derivative, production thereof and use thereof |
| DE4317458A1 (de) | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
| CA2155871A1 (en) | 1993-02-19 | 1994-09-01 | Makoto Ohyama | Derivatives of cyclodepsipeptide pf 1022 |
| DE4317457A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| DE4437198A1 (de) | 1994-10-18 | 1996-04-25 | Bayer Ag | Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden |
| DE4440193A1 (de) | 1994-11-10 | 1996-05-15 | Bayer Ag | Verwendung von Dioxomorpholinen zur Bekämpfung von Endoparasiten, neue Dioxomorpholine und Verfahren zur ihrer Herstellung |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| GB0402677D0 (en) | 2003-11-06 | 2004-03-10 | Novartis Ag | Organic compounds |
| AR046757A1 (es) * | 2003-12-10 | 2005-12-21 | Novartis Ag | Amidoacetonitrilos utiles como pesticidas |
| AU2005219788B2 (en) | 2004-03-05 | 2010-06-03 | Nissan Chemical Corporation | Isoxazoline-substituted benzamide compound and noxious organism control agent |
| TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| DE602007006288D1 (de) | 2006-03-10 | 2010-06-17 | Nissan Chemical Ind Ltd | Substituierte isoxazolin-verbindung und schädlingsbekämpfungsmittel |
| UA97388C2 (ru) * | 2007-02-09 | 2012-02-10 | Пфайзер Лімітед | Противопаразитарные агенты |
| JP4592819B2 (ja) * | 2007-02-09 | 2010-12-08 | ファイザー・リミテッド | 抗寄生虫剤 |
| WO2008102232A1 (en) | 2007-02-21 | 2008-08-28 | Pfizer Limited | Benzofuran antiparasitic agents |
| KR101292600B1 (ko) | 2007-05-15 | 2013-08-05 | 아벤티스 애그리컬쳐 | 아릴로아졸-2-일 시아노에틸아미노 화합물, 이의 제조방법 및 이의 사용방법 |
| CN105640952A (zh) | 2007-06-27 | 2016-06-08 | 杜邦公司 | 动物虫害控制方法 |
| EA201100421A1 (ru) | 2008-09-04 | 2011-10-31 | Зингента Партисипейшнс Аг | Инсектицидные соединения |
| EP3050874B1 (en) | 2008-11-14 | 2019-01-09 | Merial Inc. | Enantiomerially enriched aryloazol-2-yl cyanoethylamino paraciticidal compounds |
| EP2373162B1 (en) | 2008-12-03 | 2013-08-14 | Novartis AG | Amidoacetonitrile compounds and pesticidal composition thereof |
-
2012
- 2012-10-08 US US14/351,945 patent/US8962681B2/en not_active Expired - Fee Related
- 2012-10-08 CA CA2851412A patent/CA2851412A1/en not_active Abandoned
- 2012-10-08 MX MX2014004743A patent/MX2014004743A/es unknown
- 2012-10-08 JP JP2014536363A patent/JP2014530849A/ja active Pending
- 2012-10-08 EP EP12794772.9A patent/EP2768497A1/en not_active Withdrawn
- 2012-10-08 AU AU2012324491A patent/AU2012324491A1/en not_active Abandoned
- 2012-10-08 CN CN201280063028.9A patent/CN104271128A/zh active Pending
- 2012-10-08 BR BR112014009220A patent/BR112014009220A8/pt not_active IP Right Cessation
- 2012-10-08 WO PCT/IB2012/055436 patent/WO2013057624A1/en active Application Filing
- 2012-10-18 JP JP2012230471A patent/JP2013087120A/ja active Pending
- 2012-10-18 AR ARP120103892A patent/AR088461A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013057624A9 (en) | 2014-10-30 |
| US20140243408A1 (en) | 2014-08-28 |
| CA2851412A1 (en) | 2013-04-25 |
| JP2013087120A (ja) | 2013-05-13 |
| JP2014530849A (ja) | 2014-11-20 |
| EP2768497A1 (en) | 2014-08-27 |
| CN104271128A (zh) | 2015-01-07 |
| AU2012324491A1 (en) | 2014-04-17 |
| US8962681B2 (en) | 2015-02-24 |
| BR112014009220A8 (pt) | 2017-06-20 |
| WO2013057624A1 (en) | 2013-04-25 |
| MX2014004743A (es) | 2014-08-01 |
| BR112014009220A2 (pt) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ592801A (en) | Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | |
| PE20151091A1 (es) | Agentes inductores de apoptosis para el tratamiento de cancer y enfermedades inmunes y autoinmunes | |
| RU2460730C2 (ru) | Новые производные n-(8-гетероарилтетрагидронафталин-2-ил)-или n-(5-гетероарилхроман-3-ил)-карбоксамида для лечения боли | |
| PE20141067A1 (es) | Compuestos para el tratamiento de la adiccion | |
| NZ607794A (en) | N-acylsulfonamide apoptosis promoters | |
| NZ603198A (en) | Novel hydroxamic acid derivative | |
| RU2017127135A (ru) | Терапевтическое средство против рака желчных протоков | |
| BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
| RU2014132884A (ru) | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний | |
| BR112015021027A2 (pt) | compostos terapêuticos | |
| EA201500266A1 (ru) | Ингибиторы репликации вирусов гриппа | |
| RU2010150911A (ru) | Амидное соединение | |
| PE20170705A1 (es) | Nuevos compuestos como inhibidores de ret (reorganizado durante la transfeccion) | |
| PE20110062A1 (es) | N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo | |
| RU2016117941A (ru) | Фениколовые противобактериальные средства | |
| RU2016105511A (ru) | Сульфонамиды в качестве молдуляторов натриевых каналов | |
| AR084174A1 (es) | Compuestos de imidazol-2-benzamida utiles para el tratamiento de osteoartritis y una composicion farmaceutica | |
| AR051965A1 (es) | Sales de la n-[2-( { (3r)-1-[trans-4-hidroxi-4-(6- metoxipiridin-3-il)-ciclohexil] pirrolidin-3- il} amino)-2- oxoetil]-3-(trifluormetil) benzamida | |
| PE20140826A1 (es) | Compuestos sustituidos fungicidas de 2-[2-halogenalquil-4-(fenoxi)-fenil]-1-[1,2,4]triazol-1-il-etanol | |
| CY1113547T1 (el) | Διαδικασια συνθεσης ενωσεων χρησιμων στην αντιμετωπιση της ηπατιτιδας c | |
| PE20061098A1 (es) | COMPUESTOS IMIDAZO[1,2-a] PIRIDINILO COMO INHIBIDORES DE VEGF-R2 | |
| CL2011002631A1 (es) | Formulacion farmaceutica liquida que comprende una sal de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina (vortioxetina) seleccionada entre la sal de adicion de acido dl-lactico, l-lactico y d-lactico; uso de la sal para el tratamiento de trastorno depresivo mayor y ansiedad generalizada, entre otras; y formas cristalinas del compuesto. | |
| AR110155A2 (es) | ALCOHOLES TRIFLUOROMETÍLICOS COMO MODULADORES DE RORgT | |
| NZ604035A (en) | Glycine transporter-1 inhibitors, methods of making them, and uses thereof | |
| RU2017117566A (ru) | Активатор kcnq2-5 каналов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |